UU
UTEC- University of Tokyo Edge Capital
Venture CapitalActiveThe University of Tokyo Edge Capital is an early-stage, technology-focused venture firm associated with The University of Tokyo in Japan.
89
Investments
2
Exits
$500M
AUM
2.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for UTEC- University of Tokyo Edge Capital.
Investment Thesis & Strategy
UTEC invests in early-stage, technology-focused companies, with a particular interest in those emerging from universities, especially in the fintech sector. They are associated with the University of Tokyo in Japan.
Investment Activity
Deals per year over the last 5 years
2
20174
20180
20193
20203
2021Portfolio Companies
Selected investments from their portfolio of 89 companies
D
DeepSkill
EdTech · Seed, 2021
Q
Quantum Biosystems
Biotech · Seed, 2021
P
PLIMES
Biotech · Seed, 2021
A
Aillis
AI/ML · Seed, 2020
C
CellFiber
Biotech · Seed, 2020
T
TRIPLE-DEE
Healthcare · Seed, 2020
S
Synspective
Other · Series A, 2018
d
dotData
AI/ML · Series A, 2018
E
ELIX
Biotech · Series A, 2018
H
Hacarus
AI/ML · Series A, 2018
A
Araya
AI/ML · Series A, 2017
I
I'rom
Healthcare · Series A, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
SpiberIPO2024—
TBMIPO2021—
Frequently Asked Questions
UTEC- University of Tokyo Edge Capital focuses on Series A, Series B, Series C+ stage investments.